AstraZeneca pulls out of bid to hold Covid-19 vaccine trials in Philippines; virus cases almost reaching 450,000


People wearing face masks and face shields shop for Christmas lanterns at a store in Las Pinas City, Metro Manila, Philippines. The Covid-19 cases on Saturday (Dec 12) was almost reaching 450,000, announced the DOH of the Philippines. - Reuters

MANILA, Dec 12 (Xinhua): AstraZeneca, the Britain-based drug maker, has withdrawn its application to conduct Covid-19 vaccine clinical trials in the Philippines, the country's Food and Drug Administration (FDA) has announced.

"They (AstraZeneca) said they have enough data already," Enrique Domingo, the FDA director general, said in a text message to Xinhua, explaining the reason AstraZeneca cited for withdrawing trials application.

The Star Christmas Special Promo: Save 35% OFF Yearly. T&C applies.

Monthly Plan

RM 13.90/month

Best Value

Annual Plan

RM 12.33/month

RM 8.02/month

Billed as RM 96.20 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Aseanplus News

Asean news headlines as of 10pm on Tuesday (Dec 23)
Nearly five years’ jail for Singapore man who used different schemes to cheat 37 victims of over S$1.4mil
Bangladesh summons Indian envoy as protest erupts in New Delhi
Cambodia earns US$14.83bil from exports of garments, footwear in Jan-Nov
Philippine live births fall to around 1.36 million in 2024
Heavy congestion expected at Brunei's border during holiday period
Sabah MACC proposes governance improvements for state rural housing programme
Myanmar nationals caught with 10 drones in Bangkok: Police
Taiwan metro attack suspect's parents apologise after deadly stabbing
Christmas spirit lights up HCM City streets

Others Also Read